Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 8/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 8/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 7/20 | 0.39 |
| ▸ | TUBB1 | Q9H4B7 | 8/20 | 0.37 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.34 |
| ▸ | TUBB4A | P04350 | 2/20 | 0.34 |
| ▸ | TUBB | P07437 | 2/20 | 0.34 |
| ▸ | TUBA3C | P0DPH7 | 2/20 | 0.34 |
| ▸ | TUBA1B | P68363 | 2/20 | 0.34 |
| ▸ | TUBA4A | P68366 | 2/20 | 0.34 |
| ▸ | TUBB4B | P68371 | 2/20 | 0.34 |
| ▸ | TUBB3 | Q13509 | 2/20 | 0.34 |
| ▸ | TUBB2A | Q13885 | 2/20 | 0.34 |
| ▸ | TUBB8 | Q3ZCM7 | 2/20 | 0.34 |
| ▸ | TUBA3E | Q6PEY2 | 2/20 | 0.34 |
| ▸ | TUBA1A | Q71U36 | 2/20 | 0.34 |
| ▸ | TUBA1C | Q9BQE3 | 2/20 | 0.34 |
| ▸ | TUBB6 | Q9BUF5 | 2/20 | 0.34 |
| ▸ | TUBB2B | Q9BVA1 | 2/20 | 0.34 |
| ▸ | RELA | Q04206 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15701941 | 0.79 | PTGS1 (0.42) | PTGS1PTGS2ALOX5TUBB1NFE2L2 | |
| SCHEMBL810292 | 0.76 | TP53 (0.41) | TAAR1 | |
| SCHEMBL14448167 | 0.72 | ALDH1A1 (0.52) | TAAR1 | |
| SCHEMBL606261 | 0.72 | TAAR1 (0.56) | TAAR1 | |
| SCHEMBL3692946 | 0.71 | ALDH1A1 (0.44) | PTGS1PTGS2ALOX5TUBB1NFE2L2 | |
| SCHEMBL3692947 | 0.71 | ALDH1A1 (0.44) | PTGS1PTGS2ALOX5TUBB1NFE2L2 | |
| SCHEMBL5509294 | 0.68 | ALDH1A1 (0.44) | — | |
| SCHEMBL27804944 | 0.66 | TAAR1 (0.34) | TAAR1 | |
| SCHEMBL14546327 | 0.66 | TAAR1 (0.34) | TAAR1 | |
| SCHEMBL14496730 | 0.66 | CYP3A4 (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9278959-B2 | Processes and reagents for making diaryliodonium salts | NUTECH VENTURES (US) | 2016-03-08 | — | — | US | disclosed |
| US-20140121371-A1 | PROCESSES AND REAGENTS FOR MAKING DIARYLIODONIUM SALTS | Ground Fluor Pharmaceuticals, Inc. (US) | 2014-05-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140121371-A1 | PROCESSES AND REAGENTS FOR MAKING DIARYLIODONIUM SALTS | ABL1, ARSA, AADAC | PTGS1 4771/4885PTGS2 4712/4885ALOX5 1929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.